These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3738745)

  • 1. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
    Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
    Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
    Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
    Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and neutropenia occurring during cardiopulmonary bypass.
    Hammerschmidt DE; Stroncek DF; Bowers TK; Lammi-Keefe CJ; Kurth DM; Ozalins A; Nicoloff DM; Lillehei RC; Craddock PR; Jacob HS
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):370-7. PubMed ID: 6970304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome.
    Langlois PF; Gawryl MS
    Am Rev Respir Dis; 1988 Aug; 138(2):368-75. PubMed ID: 3264125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation and vascular injury in systemic lupus erythematosus.
    Abramson S; Belmont HM; Hopkins P; Buyon J; Winchester R; Weissmann G
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():43-6. PubMed ID: 2886660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass.
    Kreutzer DL; McCormick JR; Despins A; Moore M; Rousou JH; Dobbs W; Engleman RN
    J Exp Pathol; 1984; 1(3):183-7. PubMed ID: 6336305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.
    Rubens FD; Nathan H; Labow R; Williams KS; Wozny D; Karsh J; Ruel M; Mesana T
    Ann Thorac Surg; 2005 Feb; 79(2):655-65. PubMed ID: 15680854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement and the damaging effects of cardiopulmonary bypass.
    Westaby S
    Thorax; 1983 May; 38(5):321-5. PubMed ID: 6603674
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement-mediated neutrophil activation in sepsis- and trauma-related adult respiratory distress syndrome. Clarification with radioaerosol lung scans.
    Tennenberg SD; Jacobs MP; Solomkin JS
    Arch Surg; 1987 Jan; 122(1):26-32. PubMed ID: 3541851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation and endotoxin in sepsis.
    Padalino P; Gardinali M; Pallavicini J; Chiara O; Bisiani G; Nespoli A
    Prog Clin Biol Res; 1989; 308():277-82. PubMed ID: 2780700
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
    Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
    Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methylprednisolone on complement activation during heparin neutralization.
    Loubser PG
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):23-7. PubMed ID: 9007666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal complement complexes and anaphylatoxins in septic and ischemic patients.
    Heideman M; Norder-Hansson B; Bengtson A; Mollnes TE
    Arch Surg; 1988 Feb; 123(2):188-92. PubMed ID: 3277584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface receptor mobilization in complement-mediated neutrophil activation: characterization and effects of methylprednisolone.
    Tennenberg SD; Solomkin JS
    J Surg Res; 1987 Aug; 43(2):143-8. PubMed ID: 3041104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
    Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
    N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of loss of human neutrophil chemotaxis following thermal injury.
    Nelson RD; Hasslen SR; Ahrenholz DH; Solem LD
    J Burn Care Rehabil; 1987; 8(6):496-502. PubMed ID: 3436972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.
    Stevens JH; O'Hanley P; Shapiro JM; Mihm FG; Satoh PS; Collins JA; Raffin TA
    J Clin Invest; 1986 Jun; 77(6):1812-6. PubMed ID: 3711336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
    Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
    Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.